Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
- Stockomendation Crowdfunding on Seedrs NOW!
- Hold Photo-Me International (PHTM) by Kepler Cheuvreux
- Hold McCarthy & Stone (MCS) by Berenberg
- Sell Plus500 Ltd (DI) (PLUS) by Canaccord Genuity
- Stockomendation Crowdfunding on Seedrs NOW!
- Hold WANdisco (WAND) by Tom Winnifrith in Hot Stock Rockets
- Buy Bunzl (BNZL) by Royston Wild in The Motley Fool
- Buy Jersey Electricity 'A' Shares (JEL) by G A Chester in The Motley Fool
- Stockomendation Crowdfunding on Seedrs NOW!
- Buy National Grid (NG.) by G A Chester in The Motley Fool
- Avoid Nanoco Group (NANO) by Steve Moore in ShareProphets
- Sell Tungsten Corporation (TUNG) by Steve Moore in ShareProphets
- Stockomendation Crowdfunding on Seedrs NOW!
- Buy Admiral Group (ADM) by Goldman Sachs
- Buy Meggitt (MGGT) by Citi
- Buy Driver Group (DRV) by Edmond Jackson in Interactive Investor
- Stockomendation Crowdfunding on Seedrs NOW!
- Buy PZ Cussons (PZC) by Chris Bailey in Five Free Share Tips
- Avoid Balfour Beatty (BBY) by Roland Head in The Motley Fool
- Buy Aggreko (AGK) by Roland Head in The Motley Fool
- Stockomendation Crowdfunding on Seedrs NOW!
- Buy SThree (STHR) by Peter Stephens in The Motley Fool
- Buy Taylor Wimpey (TW.) by Peter Stephens in The Motley Fool
- Buy Aviva (AV.) by Rupert Hargreaves in The Motley Fool
- Stockomendation Crowdfunding on Seedrs NOW!
- Buy Carnival (CCL) by Rupert Hargreaves in The Motley Fool
- Hold Sports Direct International (SPD) by Peel Hunt
AstraZeneca (AZN)
Pharma and Biotech Sector
-
Latest quote
6,130.00p (mid)
-
Current Change (%)
0.02%
-
Price
Bid: 6,102.00p
Offer: 6,104.00p
-
Today
High: 6,158.00p
Low: 6,069.00p
-
This year
High: 6,317.00p
Low: 4,712.50p
-
Information
Volume: 758,988
Market Cap: £77605.8M
AstraZeneca Overview
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.AstraZeneca RNS Feed
| Title | Release date |
|---|---|
| Update on the Phase III EAGLE trial of Imfinzi | 07:00 - December 7, 2018 |
| Divestment of rights to Covis completed | 07:00 - December 6, 2018 |
| Director/PDMR Shareholding | 15:00 - December 4, 2018 |
| Total Voting Rights | 16:00 - December 3, 2018 |
| Block listing Interim Review | 16:00 - December 3, 2018 |
| Grünenthal Agreement for Nexium, Vimovo Completed | 07:00 - December 3, 2018 |
| US FDA grants Fasenra ODD for EGPA | 07:00 - November 26, 2018 |
| AstraZeneca provides update on Phase III MYSTIC | 07:00 - November 16, 2018 |
| AstraZeneca to divest US Synagis rights to Sobi | 07:00 - November 13, 2018 |
| US FDA accepts regulatory submission for Lynparza | 07:05 - November 12, 2018 |
| Farxiga significantly reduced hospitalisation for | 07:00 - November 12, 2018 |
| AZN: Year-to-Date and Q3 2018 Results | 07:00 - November 8, 2018 |
| Divestment of rights to Covis Pharma | 07:00 - November 6, 2018 |
| Total Voting Rights | 15:00 - November 1, 2018 |
| Additional financial information-Grünenthal deal | 09:45 - October 31, 2018 |
NOTE: This is based on 192 open tips for this company
